HRTX

Heron Therapeutics, Inc.

1 day chart

About HRTX

Heron Therapeutics, Inc. is a commercial-stage biotechnology company. The Company commercializes a portfolio of products to care for acute care and oncology patients. Its oncology care product portfolio includes SUSTOL and CINVANTI. SUSTOL is used for the prevention of acute and delayed nausea and vomiting associated with both moderately emetogenic chemotherapy (MEC), and anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. CINVANTI is an intravenous (IV) formulation of aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist. Its acute care product portfolio includes ZYNRELEF, HTX-019, and HTX-034. HTX- ZYNRELEF is a dual-acting local anaesthetic that delivers a fixed-dose combination of the local anaesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam. HTX-019 is an investigational agent for the prevention of postoperative nausea and vomiting in adults. HTX-034 is a product candidate for postoperative pain management.

Buy US stocks in Australia starting with HRTX. Open an account and start investing today!

Market Capitalisation

$159.22M

Price-earnings ratio

Dividend yield

0.00%

Volume

High today

$1.33

Low today

$1.26

Open price

$0.00

52-week high

$5.62

52-week low

$1.07

HRTX FAQs

Can I buy HRTX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy HRTX shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Heron Therapeutics, Inc.?

One share of Heron Therapeutics, Inc. is valued at $1.30.

What is the ticker symbol for Heron Therapeutics, Inc.?

The ticker symbol for Heron Therapeutics, Inc. is HRTX.

How do I buy HRTX shares in Australia?

To buy HRTX stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in HRTX

What is the 52-week high for Heron Therapeutics, Inc. stock?

The Heron Therapeutics, Inc. 52-week high stock price is $5.62.

What is the 52-week low for Heron Therapeutics, Inc. stock?

The Heron Therapeutics, Inc. 52-week low stock price is $1.07.

What is the market capitalisation of Heron Therapeutics, Inc. HRTX?

As of 25/05/2023 Heron Therapeutics, Inc. has a market cap of $159M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.